Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery
Biochemistry and Cell Biology · 2024
DOI: 10.1139/bcb-2024-0004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemistry and Cell Biology, 2024. Verfasst von Lucas Penny und 3 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada. Hauptthemen laut MEDLINE: Nucleosomes, Biomarkers, Tumor, Neoplasms, Chromatin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Doctoral Research Training Award from Canadian Cancer Society, Canadian Institute of Health Research (CIHR) Fredrick Banting and Charles Best Canada Graduate Doctoral Scholarship, Gattuso-Slaight Personalized Cancer Medicine Fund at the Princess Margaret Cancer Centre.
Abstract (Originalsprache)
Cell-free DNA (cfDNA) from the bloodstream has been studied for cancer biomarker discovery, and chromatin-derived epigenetic features have come into the spotlight for their potential to expand clinical applications. Methylation, fragmentation, and nucleosome positioning patterns of cfDNA have previously been shown to reveal epigenomic and inferred transcriptomic information. More recently, histone modifications have emerged as a tool to further identify tumor-specific chromatin variants in plasma. A number of sequencing methods have been developed to analyze these epigenetic markers, offering new insights into tumor biology. Features within cfDNA allow for cancer detection, subtype and tissue of origin classification, and inference of gene expression. These methods provide a window into the complexity of cancer and the dynamic nature of its progression. In this review, we highlight the array of epigenetic features in cfDNA that can be extracted from chromatin- and nucleosome-associated organization and outline potential use cases in cancer management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
- Department of Radiation Oncology, University of Toronto, Toronto, ON M5T 1P5, Canada.
ORCID-Profile: Lucas Penny, Sasha C Main, Steven D De Michino, Scott V Bratman
Förderung
- Doctoral Research Training Award from Canadian Cancer Society
- Canadian Institute of Health Research (CIHR) Fredrick Banting and Charles Best Canada Graduate Doctoral Scholarship
- Gattuso-Slaight Personalized Cancer Medicine Fund at the Princess Margaret Cancer Centre
- Dr. Mariano Elia Chair in Head & Neck Cancer Research at the University Health Network and the University of Toronto
- Ontario Graduate Scholarship at the University of Toronto
Zitieren
APA
Penny, L., Main, S. C., De Michino, S. D., & Bratman, S. V. (2024). Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2024-0004
Vancouver
Penny L, Main SC, De Michino SD, Bratman SV. Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery. Biochemistry and Cell Biology. 2024. doi:10.1139/bcb-2024-0004
BibTeX
@article{Penny2024,
author = {Penny, Lucas and Main, Sasha C and De Michino, Steven D and Bratman, Scott V},
title = {Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery},
journal = {Biochemistry and Cell Biology},
year = {2024},
doi = {10.1139/bcb-2024-0004}
}
EUVIMED